Natixis Bleichroeder Downgrades Kendle International (KNDL) to Hold
More News related to KNDL
- Goldman Sachs Upgrades Parexel (PRXL) to Neutral, Downgrades Kendle (KNDL) to Sell
- After-Hours Movers 11/04: RSOL, SANM, PARL, VLNC, GIVN, CECO Higher; SMSI, AUTH, WFMI, ANDE Lower
- Kendle (KNDL) Reports Q3 EPS of $0.59
- Kendle Announces Third Quarter 2009 Results
- Trading Radar for 11/04: Cisco (CSCO), Comcast (CMCSA), Tyco (TEL), Molson Coors (TAP) Report
More News related to Downgrades
- Shields & Co. Downgrades ALLETE, Inc. (ALE) to Hold
- Scotia Capital Downgrades Grupo Aeroportuario del Centro (OMAB) to Sector Perform
- Goldman Sachs Upgrades Bradesco and Banco do Brasil; Downgrades Bancolombia
- Wedbush Downgrades Burger King (BKC) to Underperform
- Morgan Stanley Upgrades Safeway (SWY), Downgrades SUPERVALU (SVU)
Natixis Bleichroeder downgrades Kendle International (Nasdaq: KNDL) from Buy to Hold. Price target $10.
To see more analyst ratings on KNDL Click Here.
Kendle International Inc., a clinical research organization, provides clinical development services on a contract basis to the biopharmaceutical industry worldwide.
Related Categories
DowngradesStocks Mentioned
-0.44Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
